Precision Tracking of Samples Enabled at Low Temperatures
|
By LabMedica International staff writers Posted on 28 Feb 2012 |
|
Image: Each vial is tagged with a unique RFID identifier. The RFID tag is integrated into the vial – it cannot be removed, or fall off inadvertently (Photo courtesy of Biotillion).
A new solution enables real-time (RT) precision tracking of samples in situ at low temperatures.
Difficulties in tracking samples are due to the inability to locate automatically the samples, as well as a lack of robust connection between the physical sample and archiving software. The task is further complicated at ultra low temperatures.
The ColdTrack platform was designed to solve these problems. The platform enables electronic tracking by associating a unique electronic tag with each sample, enabling fast mapping of sample boxes.
Tens of millions of new biological samples are collected and stored annually by pharmaceutic companies, universities, hospitals, diagnostic testing and research centers, national genetic databases, and forensic laboratories.
BioTillion (Skillman, NJ, USA), a privately held company, introduced the ColdTrack platform at the SLAS 2012 meeting in San Diego (CA, USA), which was held in February 2012.
Each ColdTrack sample vial has unique radio frequency identification (RFID) tag that cannot be changed or replicated in another, and contains user-defined data that may be modified by a user. The RFID-tagged vials survive exposure to a wide range of temperatures: from liquid nitrogen temperatures (-196 °C) up to the maximum operating temperature of the vial (121 °C) without loss of data or functionality.
A freezer box is mapped by placing the box containing one or more ColdTrack vials on a BoxMapper. The BoxMapper can map the contents of an 81-sample freezer box in about a second. The reader is connected to a computer using a USB cable.
The BoxMapper is integrated with a group of laboratory information-management systems (LIMS) packages. The details of the CDR-LIMS interaction is slightly different for each LIMS package but in all cases the box contents are transferred to the LIMS program automatically so that the user does not need to enter vial IDs or box locations.
Related Links:
BioTillion
SLAS 2012 meeting
.jpg)
Difficulties in tracking samples are due to the inability to locate automatically the samples, as well as a lack of robust connection between the physical sample and archiving software. The task is further complicated at ultra low temperatures.
The ColdTrack platform was designed to solve these problems. The platform enables electronic tracking by associating a unique electronic tag with each sample, enabling fast mapping of sample boxes.
Tens of millions of new biological samples are collected and stored annually by pharmaceutic companies, universities, hospitals, diagnostic testing and research centers, national genetic databases, and forensic laboratories.
BioTillion (Skillman, NJ, USA), a privately held company, introduced the ColdTrack platform at the SLAS 2012 meeting in San Diego (CA, USA), which was held in February 2012.
Each ColdTrack sample vial has unique radio frequency identification (RFID) tag that cannot be changed or replicated in another, and contains user-defined data that may be modified by a user. The RFID-tagged vials survive exposure to a wide range of temperatures: from liquid nitrogen temperatures (-196 °C) up to the maximum operating temperature of the vial (121 °C) without loss of data or functionality.
A freezer box is mapped by placing the box containing one or more ColdTrack vials on a BoxMapper. The BoxMapper can map the contents of an 81-sample freezer box in about a second. The reader is connected to a computer using a USB cable.
The BoxMapper is integrated with a group of laboratory information-management systems (LIMS) packages. The details of the CDR-LIMS interaction is slightly different for each LIMS package but in all cases the box contents are transferred to the LIMS program automatically so that the user does not need to enter vial IDs or box locations.
Related Links:
BioTillion
SLAS 2012 meeting
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
HPV Test
Allplex HPV28 Detection
Latest Technology News
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
Channels
Clinical Chemistry
view channel
Alzheimer’s Biomarkers Identify Faster Cognitive Decline in Adults Over 80
Diagnosing the cause of cognitive decline in adults over 80 is challenging because multiple comorbidities can blur early clinical presentations. As a result, memory complaints are often attributed to normal... Read more
ADLM Issues Laboratory Guidance for Gender-Diverse Patient Care
Laboratory medicine increasingly intersects with gender-affirming care, where hormone therapy and rigid health record fields can complicate the interpretation of routine tests. Without appropriate clinical... Read more
Molecular Diagnostics
view channel
Blood Test Helps Guide Post-Surgical Treatment in Metastatic Colorectal Cancer
Colorectal cancer is the third most common malignancy worldwide and the second-leading cause of cancer death. The liver is the most frequent site of spread, and although surgery offers the best chance... Read more
Blood Test Using Circular RNA Biomarkers Predicts Alzheimer’s Progression
Alzheimer’s disease evaluation commonly relies on plasma phosphorylated tau 217, along with invasive cerebrospinal fluid (CSF) testing and expensive PET. Blood-based approaches that can stratify risk years... Read more
Hematology
view channel
Blood Test Helps Predict Short-Term Mortality After Severe Heart Attack
ST-elevation myocardial infarction (STEMI) is a severe heart attack caused by complete blockage of a coronary artery. Early risk stratification at hospital admission is challenging but essential for guiding... Read more
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Immunology
view channel
Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms
Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read more
Emergency Department Opt-Out Testing Program Identifies Undiagnosed HIV
Undiagnosed HIV continues to drive avoidable morbidity and transmission, with many people identified only after substantial immune damage has occurred. In England, about one in 20 people living with HIV... Read more
Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission
Severe traumatic injury can trigger immune and organ dysfunction that complicates recovery in the intensive care unit. A subset of patients develop chronic critical illness, defined as dependence on intensive... Read more
Microbiology
view channel
Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
Acute infectious gastroenteritis remains a major cause of illness worldwide, especially in young children, older adults, and immunocompromised patients. Nonspecific symptoms such as diarrhea, vomiting,... Read more
H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read more
Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
Colorectal cancer has been repeatedly linked to alterations in the gut microbiome, yet findings have often varied across small, heterogeneous studies. Reproducibility has been limited by differing sequencing... Read more
Pathology
view channel
EBV Status Helps Predict Survival in Primary CNS Lymphoma
Primary central nervous system lymphoma is a rare malignancy in which tumors arise in the brain and, less often, the spinal cord, eyes, or cerebrospinal fluid. Outcomes are especially variable when the... Read more
AI Pathology Tool Predicts Immunotherapy Response in Rare Cancers
Immunotherapy has transformed care for select malignancies, yet predicting which patients with rare cancers are most likely to benefit remains challenging. Clinicians often have only limited biomarkers... Read more
Industry
view channel
Eurobio Scientific Completes Acquisition of CareDx Lab Products Division
Eurobio Scientific has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitute CareDx’s Lab Products division. The business will... Read more
Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia
Colombia remains a high-priority setting for tuberculosis, with a growing need for diagnostics that complement existing testing strategies and improve access to earlier diagnosis. Solutions that function... Read more
